These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6539222

  • 1. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?
    Ratzmann KP, Strese J, Keilacker H, Giebelmann R, Scheibe F, Witt S.
    Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222
    [Abstract] [Full Text] [Related]

  • 2. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.
    Shor M, Boaz M, Gavish D, Wainshtein J, Matas Z, Shargorodsky M.
    Am J Cardiol; 2007 Dec 15; 100(12):1767-70. PubMed ID: 18082523
    [Abstract] [Full Text] [Related]

  • 3. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Dec 15; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy.
    Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirer O, Parving HH.
    Nephrol Dial Transplant; 1996 Jun 15; 11(6):1019-23. PubMed ID: 8671962
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent.
    Awadallah S, Hamad M.
    Cytobios; 2000 Jun 15; 101(398):145-50. PubMed ID: 10755213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K.
    N Engl J Med; 2000 Sep 28; 343(13):969-70. PubMed ID: 11012324
    [No Abstract] [Full Text] [Related]

  • 11. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U, Ventriglia L, Iavicoli M, Guy K, Andreani D.
    Clin Exp Immunol; 1983 Jun 28; 52(3):575-80. PubMed ID: 6603299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
    Orchard TJ, Forrest KY, Ellis D, Becker DJ.
    Arch Intern Med; 1997 Sep 08; 157(16):1851-6. PubMed ID: 9290544
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum C4 concentration and diabetic microangiopathy in insulin dependent diabetes. A study of an Italian group of insulin dependent diabetic patients.
    Altomonte L, Zoli A, Mirone L, Mangia A, Masucci M, Ghirlanda G, Greco AV.
    Panminerva Med; 1987 Sep 08; 29(4):307-10. PubMed ID: 3431891
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.